nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—Cisplatin—testicular cancer	0.137	0.505	CbGbCtD
Clodronate—PTGS2—Etoposide—testicular cancer	0.135	0.496	CbGbCtD
Clodronate—SLC25A6—embryo—testicular cancer	0.0304	0.115	CbGeAlD
Clodronate—SLC25A5—embryo—testicular cancer	0.0264	0.0997	CbGeAlD
Clodronate—SLC25A5—seminal vesicle—testicular cancer	0.0248	0.0937	CbGeAlD
Clodronate—SLC25A6—gonad—testicular cancer	0.0206	0.0778	CbGeAlD
Clodronate—SLC25A5—gonad—testicular cancer	0.0179	0.0677	CbGeAlD
Clodronate—SLC25A6—Vinorelbine—Vinblastine—testicular cancer	0.0176	1	CbGdCrCtD
Clodronate—SLC25A4—gonad—testicular cancer	0.0168	0.0634	CbGeAlD
Clodronate—SLC25A6—female gonad—testicular cancer	0.0168	0.0632	CbGeAlD
Clodronate—SLC25A6—testis—testicular cancer	0.0149	0.0561	CbGeAlD
Clodronate—SLC25A5—female gonad—testicular cancer	0.0146	0.055	CbGeAlD
Clodronate—SLC25A4—female gonad—testicular cancer	0.0137	0.0516	CbGeAlD
Clodronate—SLC25A5—testis—testicular cancer	0.0129	0.0488	CbGeAlD
Clodronate—SLC25A4—testis—testicular cancer	0.0121	0.0457	CbGeAlD
Clodronate—SLC25A6—lymph node—testicular cancer	0.0108	0.0407	CbGeAlD
Clodronate—SLC25A5—lymph node—testicular cancer	0.00937	0.0354	CbGeAlD
Clodronate—SLC25A4—lymph node—testicular cancer	0.00878	0.0331	CbGeAlD
Clodronate—PTGS2—embryo—testicular cancer	0.00498	0.0188	CbGeAlD
Clodronate—PTGS2—seminal vesicle—testicular cancer	0.00467	0.0176	CbGeAlD
Clodronate—Extravasation—Dactinomycin—testicular cancer	0.00393	0.00881	CcSEcCtD
Clodronate—Hyperphosphataemia—Doxorubicin—testicular cancer	0.00377	0.00844	CcSEcCtD
Clodronate—Hypocalcaemia—Dactinomycin—testicular cancer	0.00374	0.00839	CcSEcCtD
Clodronate—Renal failure acute—Chlorambucil—testicular cancer	0.00373	0.00837	CcSEcCtD
Clodronate—Neoplasm malignant—Ifosfamide—testicular cancer	0.00368	0.00825	CcSEcCtD
Clodronate—Extravasation—Ifosfamide—testicular cancer	0.0036	0.00807	CcSEcCtD
Clodronate—Proteinuria—Ifosfamide—testicular cancer	0.00357	0.00801	CcSEcCtD
Clodronate—Wheezing—Bleomycin—testicular cancer	0.00357	0.008	CcSEcCtD
Clodronate—Protein urine present—Ifosfamide—testicular cancer	0.00352	0.0079	CcSEcCtD
Clodronate—Hypocalcaemia—Ifosfamide—testicular cancer	0.00343	0.00769	CcSEcCtD
Clodronate—Infection—Carboplatin—testicular cancer	0.00327	0.00734	CcSEcCtD
Clodronate—Extravasation—Cisplatin—testicular cancer	0.0031	0.00696	CcSEcCtD
Clodronate—Extravasation—Etoposide—testicular cancer	0.00284	0.00637	CcSEcCtD
Clodronate—PTGS2—female gonad—testicular cancer	0.00274	0.0104	CbGeAlD
Clodronate—Hepatocellular injury—Cisplatin—testicular cancer	0.00271	0.00607	CcSEcCtD
Clodronate—Pneumonia—Chlorambucil—testicular cancer	0.00267	0.00599	CcSEcCtD
Clodronate—Wheezing—Cisplatin—testicular cancer	0.00263	0.0059	CcSEcCtD
Clodronate—Hepatic function abnormal—Ifosfamide—testicular cancer	0.00261	0.00585	CcSEcCtD
Clodronate—Local reaction—Epirubicin—testicular cancer	0.00251	0.00563	CcSEcCtD
Clodronate—Renal failure acute—Ifosfamide—testicular cancer	0.00247	0.00554	CcSEcCtD
Clodronate—Renal impairment—Ifosfamide—testicular cancer	0.0024	0.00537	CcSEcCtD
Clodronate—Cardiac failure—Ifosfamide—testicular cancer	0.00234	0.00524	CcSEcCtD
Clodronate—Local reaction—Doxorubicin—testicular cancer	0.00232	0.00521	CcSEcCtD
Clodronate—Bronchospasm—Bleomycin—testicular cancer	0.00227	0.00509	CcSEcCtD
Clodronate—Serum creatinine increased—Epirubicin—testicular cancer	0.00226	0.00507	CcSEcCtD
Clodronate—Liver disorder—Methotrexate—testicular cancer	0.00218	0.00489	CcSEcCtD
Clodronate—Pharyngitis—Vinblastine—testicular cancer	0.00217	0.00486	CcSEcCtD
Clodronate—Dysphagia—Dactinomycin—testicular cancer	0.00215	0.00482	CcSEcCtD
Clodronate—Blood creatinine increased—Ifosfamide—testicular cancer	0.00214	0.00479	CcSEcCtD
Clodronate—Renal failure acute—Cisplatin—testicular cancer	0.00213	0.00477	CcSEcCtD
Clodronate—Serum creatinine increased—Doxorubicin—testicular cancer	0.00209	0.00469	CcSEcCtD
Clodronate—Pneumonia—Bleomycin—testicular cancer	0.00207	0.00464	CcSEcCtD
Clodronate—Hypercalcaemia—Epirubicin—testicular cancer	0.002	0.00449	CcSEcCtD
Clodronate—Bronchospasm—Ifosfamide—testicular cancer	0.00194	0.00435	CcSEcCtD
Clodronate—Pneumonia—Dactinomycin—testicular cancer	0.00193	0.00432	CcSEcCtD
Clodronate—Anaemia—Chlorambucil—testicular cancer	0.00192	0.0043	CcSEcCtD
Clodronate—Angioedema—Chlorambucil—testicular cancer	0.0019	0.00425	CcSEcCtD
Clodronate—Hypercalcaemia—Doxorubicin—testicular cancer	0.00185	0.00415	CcSEcCtD
Clodronate—Cardiac failure—Etoposide—testicular cancer	0.00184	0.00414	CcSEcCtD
Clodronate—Blood creatinine increased—Cisplatin—testicular cancer	0.00184	0.00413	CcSEcCtD
Clodronate—Dehydration—Cisplatin—testicular cancer	0.00183	0.0041	CcSEcCtD
Clodronate—Pneumonia—Ifosfamide—testicular cancer	0.00177	0.00396	CcSEcCtD
Clodronate—PTGS2—lymph node—testicular cancer	0.00176	0.00666	CbGeAlD
Clodronate—Anaemia—Vinblastine—testicular cancer	0.00176	0.00394	CcSEcCtD
Clodronate—Renal failure—Ifosfamide—testicular cancer	0.00173	0.00387	CcSEcCtD
Clodronate—Pharyngitis—Dactinomycin—testicular cancer	0.00171	0.00383	CcSEcCtD
Clodronate—Extravasation—Methotrexate—testicular cancer	0.0017	0.00382	CcSEcCtD
Clodronate—Proteinuria—Methotrexate—testicular cancer	0.00169	0.00379	CcSEcCtD
Clodronate—Infection—Chlorambucil—testicular cancer	0.00168	0.00377	CcSEcCtD
Clodronate—Protein urine present—Methotrexate—testicular cancer	0.00167	0.00374	CcSEcCtD
Clodronate—Neoplasm malignant—Epirubicin—testicular cancer	0.00163	0.00365	CcSEcCtD
Clodronate—Anorexia—Chlorambucil—testicular cancer	0.00161	0.00362	CcSEcCtD
Clodronate—Oliguria—Methotrexate—testicular cancer	0.00161	0.00362	CcSEcCtD
Clodronate—Extravasation—Epirubicin—testicular cancer	0.00159	0.00357	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Etoposide—testicular cancer	0.00159	0.00356	CcSEcCtD
Clodronate—Urinary tract disorder—Ifosfamide—testicular cancer	0.00156	0.00349	CcSEcCtD
Clodronate—Dysphagia—Etoposide—testicular cancer	0.00156	0.00349	CcSEcCtD
Clodronate—Connective tissue disorder—Ifosfamide—testicular cancer	0.00155	0.00348	CcSEcCtD
Clodronate—Urethral disorder—Ifosfamide—testicular cancer	0.00155	0.00347	CcSEcCtD
Clodronate—Bronchospasm—Etoposide—testicular cancer	0.00153	0.00343	CcSEcCtD
Clodronate—Hypocalcaemia—Epirubicin—testicular cancer	0.00152	0.00341	CcSEcCtD
Clodronate—Oliguria—Epirubicin—testicular cancer	0.00151	0.00338	CcSEcCtD
Clodronate—Neoplasm malignant—Doxorubicin—testicular cancer	0.00151	0.00338	CcSEcCtD
Clodronate—Dyspepsia—Chlorambucil—testicular cancer	0.00149	0.00334	CcSEcCtD
Clodronate—Renal failure—Cisplatin—testicular cancer	0.00149	0.00334	CcSEcCtD
Clodronate—Anaemia—Bleomycin—testicular cancer	0.00148	0.00333	CcSEcCtD
Clodronate—Anorexia—Vinblastine—testicular cancer	0.00148	0.00332	CcSEcCtD
Clodronate—Extravasation—Doxorubicin—testicular cancer	0.00147	0.00331	CcSEcCtD
Clodronate—Decreased appetite—Chlorambucil—testicular cancer	0.00147	0.0033	CcSEcCtD
Clodronate—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00146	0.00328	CcSEcCtD
Clodronate—Creatinine increased—Epirubicin—testicular cancer	0.00146	0.00328	CcSEcCtD
Clodronate—Mediastinal disorder—Ifosfamide—testicular cancer	0.00142	0.00319	CcSEcCtD
Clodronate—Hypocalcaemia—Doxorubicin—testicular cancer	0.00141	0.00315	CcSEcCtD
Clodronate—Oliguria—Doxorubicin—testicular cancer	0.0014	0.00313	CcSEcCtD
Clodronate—Pneumonia—Etoposide—testicular cancer	0.0014	0.00313	CcSEcCtD
Clodronate—Hepatocellular injury—Epirubicin—testicular cancer	0.00139	0.00312	CcSEcCtD
Clodronate—Anaemia—Dactinomycin—testicular cancer	0.00138	0.00311	CcSEcCtD
Clodronate—Renal failure—Etoposide—testicular cancer	0.00136	0.00306	CcSEcCtD
Clodronate—Creatinine increased—Doxorubicin—testicular cancer	0.00135	0.00303	CcSEcCtD
Clodronate—Decreased appetite—Vinblastine—testicular cancer	0.00135	0.00303	CcSEcCtD
Clodronate—Urticaria—Chlorambucil—testicular cancer	0.00135	0.00302	CcSEcCtD
Clodronate—Urinary tract disorder—Cisplatin—testicular cancer	0.00134	0.00301	CcSEcCtD
Clodronate—Abdominal pain—Chlorambucil—testicular cancer	0.00134	0.003	CcSEcCtD
Clodronate—Connective tissue disorder—Cisplatin—testicular cancer	0.00134	0.003	CcSEcCtD
Clodronate—Urethral disorder—Cisplatin—testicular cancer	0.00133	0.00299	CcSEcCtD
Clodronate—Infection—Bleomycin—testicular cancer	0.0013	0.00292	CcSEcCtD
Clodronate—Hepatocellular injury—Doxorubicin—testicular cancer	0.00129	0.00288	CcSEcCtD
Clodronate—Anaemia—Ifosfamide—testicular cancer	0.00127	0.00285	CcSEcCtD
Clodronate—Angioedema—Ifosfamide—testicular cancer	0.00125	0.00281	CcSEcCtD
Clodronate—Anorexia—Bleomycin—testicular cancer	0.00125	0.0028	CcSEcCtD
Clodronate—Urinary tract disorder—Etoposide—testicular cancer	0.00123	0.00276	CcSEcCtD
Clodronate—Abdominal pain—Vinblastine—testicular cancer	0.00123	0.00275	CcSEcCtD
Clodronate—Mediastinal disorder—Cisplatin—testicular cancer	0.00123	0.00275	CcSEcCtD
Clodronate—Urethral disorder—Etoposide—testicular cancer	0.00122	0.00274	CcSEcCtD
Clodronate—Infection—Dactinomycin—testicular cancer	0.00121	0.00272	CcSEcCtD
Clodronate—Pruritus—Chlorambucil—testicular cancer	0.0012	0.00269	CcSEcCtD
Clodronate—Dyspnoea—Bleomycin—testicular cancer	0.00117	0.00262	CcSEcCtD
Clodronate—Renal failure acute—Methotrexate—testicular cancer	0.00117	0.00262	CcSEcCtD
Clodronate—Anorexia—Dactinomycin—testicular cancer	0.00117	0.00261	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00116	0.0026	CcSEcCtD
Clodronate—Diarrhoea—Chlorambucil—testicular cancer	0.00116	0.0026	CcSEcCtD
Clodronate—Hepatic function abnormal—Epirubicin—testicular cancer	0.00115	0.00259	CcSEcCtD
Clodronate—Decreased appetite—Bleomycin—testicular cancer	0.00114	0.00256	CcSEcCtD
Clodronate—Mediastinal disorder—Etoposide—testicular cancer	0.00112	0.00252	CcSEcCtD
Clodronate—Infection—Ifosfamide—testicular cancer	0.00111	0.0025	CcSEcCtD
Clodronate—Anaemia—Cisplatin—testicular cancer	0.00109	0.00245	CcSEcCtD
Clodronate—Renal failure acute—Epirubicin—testicular cancer	0.00109	0.00245	CcSEcCtD
Clodronate—Skin disorder—Ifosfamide—testicular cancer	0.00109	0.00244	CcSEcCtD
Clodronate—Vomiting—Chlorambucil—testicular cancer	0.00108	0.00242	CcSEcCtD
Clodronate—Hepatic function abnormal—Doxorubicin—testicular cancer	0.00107	0.0024	CcSEcCtD
Clodronate—Anorexia—Ifosfamide—testicular cancer	0.00107	0.00239	CcSEcCtD
Clodronate—Decreased appetite—Dactinomycin—testicular cancer	0.00106	0.00238	CcSEcCtD
Clodronate—Diarrhoea—Vinblastine—testicular cancer	0.00106	0.00238	CcSEcCtD
Clodronate—Renal impairment—Epirubicin—testicular cancer	0.00106	0.00238	CcSEcCtD
Clodronate—Urticaria—Bleomycin—testicular cancer	0.00104	0.00234	CcSEcCtD
Clodronate—Cardiac failure—Epirubicin—testicular cancer	0.00103	0.00232	CcSEcCtD
Clodronate—Renal failure acute—Doxorubicin—testicular cancer	0.00101	0.00227	CcSEcCtD
Clodronate—Nausea—Chlorambucil—testicular cancer	0.00101	0.00226	CcSEcCtD
Clodronate—Anaemia—Etoposide—testicular cancer	0.001	0.00225	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.001	0.00224	CcSEcCtD
Clodronate—Dyspnoea—Ifosfamide—testicular cancer	0.000999	0.00224	CcSEcCtD
Clodronate—Vomiting—Vinblastine—testicular cancer	0.000987	0.00221	CcSEcCtD
Clodronate—Renal impairment—Doxorubicin—testicular cancer	0.000981	0.0022	CcSEcCtD
Clodronate—Decreased appetite—Ifosfamide—testicular cancer	0.000974	0.00218	CcSEcCtD
Clodronate—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000967	0.00217	CcSEcCtD
Clodronate—Abdominal pain—Dactinomycin—testicular cancer	0.000967	0.00217	CcSEcCtD
Clodronate—Infection—Cisplatin—testicular cancer	0.00096	0.00215	CcSEcCtD
Clodronate—Cardiac failure—Doxorubicin—testicular cancer	0.000957	0.00215	CcSEcCtD
Clodronate—Blood creatinine increased—Epirubicin—testicular cancer	0.000945	0.00212	CcSEcCtD
Clodronate—Dehydration—Epirubicin—testicular cancer	0.000939	0.0021	CcSEcCtD
Clodronate—Skin disorder—Cisplatin—testicular cancer	0.000938	0.0021	CcSEcCtD
Clodronate—Pruritus—Bleomycin—testicular cancer	0.000928	0.00208	CcSEcCtD
Clodronate—Nausea—Vinblastine—testicular cancer	0.000922	0.00207	CcSEcCtD
Clodronate—Abdominal pain upper—Epirubicin—testicular cancer	0.000922	0.00207	CcSEcCtD
Clodronate—Anorexia—Cisplatin—testicular cancer	0.000921	0.00206	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000917	0.00206	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.00089	0.002	CcSEcCtD
Clodronate—Urticaria—Ifosfamide—testicular cancer	0.00089	0.002	CcSEcCtD
Clodronate—Abdominal pain—Ifosfamide—testicular cancer	0.000886	0.00199	CcSEcCtD
Clodronate—Infection—Etoposide—testicular cancer	0.000879	0.00197	CcSEcCtD
Clodronate—Blood creatinine increased—Doxorubicin—testicular cancer	0.000875	0.00196	CcSEcCtD
Clodronate—Dysphagia—Epirubicin—testicular cancer	0.000872	0.00196	CcSEcCtD
Clodronate—Dehydration—Doxorubicin—testicular cancer	0.000868	0.00195	CcSEcCtD
Clodronate—Dyspnoea—Cisplatin—testicular cancer	0.000861	0.00193	CcSEcCtD
Clodronate—Skin disorder—Etoposide—testicular cancer	0.00086	0.00193	CcSEcCtD
Clodronate—Abdominal pain upper—Doxorubicin—testicular cancer	0.000853	0.00191	CcSEcCtD
Clodronate—Anorexia—Etoposide—testicular cancer	0.000844	0.00189	CcSEcCtD
Clodronate—Decreased appetite—Cisplatin—testicular cancer	0.00084	0.00188	CcSEcCtD
Clodronate—Diarrhoea—Dactinomycin—testicular cancer	0.000837	0.00188	CcSEcCtD
Clodronate—Pneumonia—Methotrexate—testicular cancer	0.000836	0.00187	CcSEcCtD
Clodronate—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000834	0.00187	CcSEcCtD
Clodronate—Vomiting—Bleomycin—testicular cancer	0.000834	0.00187	CcSEcCtD
Clodronate—Rash—Bleomycin—testicular cancer	0.000827	0.00185	CcSEcCtD
Clodronate—Dermatitis—Bleomycin—testicular cancer	0.000826	0.00185	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000824	0.00185	CcSEcCtD
Clodronate—Renal failure—Methotrexate—testicular cancer	0.000817	0.00183	CcSEcCtD
Clodronate—Dysphagia—Doxorubicin—testicular cancer	0.000807	0.00181	CcSEcCtD
Clodronate—Pruritus—Ifosfamide—testicular cancer	0.000793	0.00178	CcSEcCtD
Clodronate—Dyspnoea—Etoposide—testicular cancer	0.000789	0.00177	CcSEcCtD
Clodronate—Pneumonia—Epirubicin—testicular cancer	0.000782	0.00175	CcSEcCtD
Clodronate—Nausea—Bleomycin—testicular cancer	0.000779	0.00175	CcSEcCtD
Clodronate—Vomiting—Dactinomycin—testicular cancer	0.000777	0.00174	CcSEcCtD
Clodronate—Rash—Dactinomycin—testicular cancer	0.000771	0.00173	CcSEcCtD
Clodronate—Decreased appetite—Etoposide—testicular cancer	0.000769	0.00173	CcSEcCtD
Clodronate—Diarrhoea—Ifosfamide—testicular cancer	0.000767	0.00172	CcSEcCtD
Clodronate—Renal failure—Epirubicin—testicular cancer	0.000765	0.00171	CcSEcCtD
Clodronate—Gastrointestinal disorder—Etoposide—testicular cancer	0.000764	0.00171	CcSEcCtD
Clodronate—Pharyngitis—Methotrexate—testicular cancer	0.00074	0.00166	CcSEcCtD
Clodronate—Urinary tract disorder—Methotrexate—testicular cancer	0.000737	0.00165	CcSEcCtD
Clodronate—Urethral disorder—Methotrexate—testicular cancer	0.000731	0.00164	CcSEcCtD
Clodronate—Nausea—Dactinomycin—testicular cancer	0.000726	0.00163	CcSEcCtD
Clodronate—Pneumonia—Doxorubicin—testicular cancer	0.000724	0.00162	CcSEcCtD
Clodronate—Vomiting—Ifosfamide—testicular cancer	0.000712	0.0016	CcSEcCtD
Clodronate—Renal failure—Doxorubicin—testicular cancer	0.000707	0.00159	CcSEcCtD
Clodronate—Rash—Ifosfamide—testicular cancer	0.000706	0.00158	CcSEcCtD
Clodronate—Dermatitis—Ifosfamide—testicular cancer	0.000706	0.00158	CcSEcCtD
Clodronate—Urticaria—Etoposide—testicular cancer	0.000703	0.00158	CcSEcCtD
Clodronate—Abdominal pain—Etoposide—testicular cancer	0.0007	0.00157	CcSEcCtD
Clodronate—Pharyngitis—Epirubicin—testicular cancer	0.000693	0.00155	CcSEcCtD
Clodronate—Urinary tract disorder—Epirubicin—testicular cancer	0.00069	0.00155	CcSEcCtD
Clodronate—Connective tissue disorder—Epirubicin—testicular cancer	0.000686	0.00154	CcSEcCtD
Clodronate—Urethral disorder—Epirubicin—testicular cancer	0.000684	0.00153	CcSEcCtD
Clodronate—Mediastinal disorder—Methotrexate—testicular cancer	0.000672	0.00151	CcSEcCtD
Clodronate—Nausea—Ifosfamide—testicular cancer	0.000666	0.00149	CcSEcCtD
Clodronate—Diarrhoea—Cisplatin—testicular cancer	0.000661	0.00148	CcSEcCtD
Clodronate—Pharyngitis—Doxorubicin—testicular cancer	0.000641	0.00144	CcSEcCtD
Clodronate—Urinary tract disorder—Doxorubicin—testicular cancer	0.000638	0.00143	CcSEcCtD
Clodronate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000635	0.00142	CcSEcCtD
Clodronate—Urethral disorder—Doxorubicin—testicular cancer	0.000633	0.00142	CcSEcCtD
Clodronate—Mediastinal disorder—Epirubicin—testicular cancer	0.000629	0.00141	CcSEcCtD
Clodronate—Pruritus—Etoposide—testicular cancer	0.000626	0.0014	CcSEcCtD
Clodronate—Vomiting—Cisplatin—testicular cancer	0.000614	0.00138	CcSEcCtD
Clodronate—Rash—Cisplatin—testicular cancer	0.000609	0.00137	CcSEcCtD
Clodronate—Dermatitis—Cisplatin—testicular cancer	0.000608	0.00136	CcSEcCtD
Clodronate—Diarrhoea—Etoposide—testicular cancer	0.000605	0.00136	CcSEcCtD
Clodronate—Anaemia—Methotrexate—testicular cancer	0.0006	0.00135	CcSEcCtD
Clodronate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000582	0.00131	CcSEcCtD
Clodronate—Nausea—Cisplatin—testicular cancer	0.000574	0.00129	CcSEcCtD
Clodronate—Vomiting—Etoposide—testicular cancer	0.000563	0.00126	CcSEcCtD
Clodronate—Anaemia—Epirubicin—testicular cancer	0.000562	0.00126	CcSEcCtD
Clodronate—Rash—Etoposide—testicular cancer	0.000558	0.00125	CcSEcCtD
Clodronate—Dermatitis—Etoposide—testicular cancer	0.000557	0.00125	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000549	0.00123	CcSEcCtD
Clodronate—Infection—Methotrexate—testicular cancer	0.000527	0.00118	CcSEcCtD
Clodronate—Nausea—Etoposide—testicular cancer	0.000526	0.00118	CcSEcCtD
Clodronate—Anaemia—Doxorubicin—testicular cancer	0.00052	0.00117	CcSEcCtD
Clodronate—Skin disorder—Methotrexate—testicular cancer	0.000515	0.00115	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000514	0.00115	CcSEcCtD
Clodronate—Anorexia—Methotrexate—testicular cancer	0.000505	0.00113	CcSEcCtD
Clodronate—Infection—Epirubicin—testicular cancer	0.000493	0.00111	CcSEcCtD
Clodronate—Skin disorder—Epirubicin—testicular cancer	0.000482	0.00108	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000475	0.00107	CcSEcCtD
Clodronate—Anorexia—Epirubicin—testicular cancer	0.000473	0.00106	CcSEcCtD
Clodronate—Dyspnoea—Methotrexate—testicular cancer	0.000473	0.00106	CcSEcCtD
Clodronate—Dyspepsia—Methotrexate—testicular cancer	0.000467	0.00105	CcSEcCtD
Clodronate—Decreased appetite—Methotrexate—testicular cancer	0.000461	0.00103	CcSEcCtD
Clodronate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000458	0.00103	CcSEcCtD
Clodronate—Infection—Doxorubicin—testicular cancer	0.000456	0.00102	CcSEcCtD
Clodronate—Skin disorder—Doxorubicin—testicular cancer	0.000446	0.001	CcSEcCtD
Clodronate—Dyspnoea—Epirubicin—testicular cancer	0.000442	0.000992	CcSEcCtD
Clodronate—Anorexia—Doxorubicin—testicular cancer	0.000437	0.000981	CcSEcCtD
Clodronate—Dyspepsia—Epirubicin—testicular cancer	0.000437	0.000979	CcSEcCtD
Clodronate—Decreased appetite—Epirubicin—testicular cancer	0.000431	0.000967	CcSEcCtD
Clodronate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000428	0.00096	CcSEcCtD
Clodronate—Urticaria—Methotrexate—testicular cancer	0.000421	0.000944	CcSEcCtD
Clodronate—Abdominal pain—Methotrexate—testicular cancer	0.000419	0.00094	CcSEcCtD
Clodronate—Dyspnoea—Doxorubicin—testicular cancer	0.000409	0.000918	CcSEcCtD
Clodronate—Dyspepsia—Doxorubicin—testicular cancer	0.000404	0.000906	CcSEcCtD
Clodronate—Decreased appetite—Doxorubicin—testicular cancer	0.000399	0.000895	CcSEcCtD
Clodronate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000396	0.000889	CcSEcCtD
Clodronate—Urticaria—Epirubicin—testicular cancer	0.000394	0.000884	CcSEcCtD
Clodronate—Abdominal pain—Epirubicin—testicular cancer	0.000392	0.000879	CcSEcCtD
Clodronate—Pruritus—Methotrexate—testicular cancer	0.000375	0.000841	CcSEcCtD
Clodronate—Urticaria—Doxorubicin—testicular cancer	0.000365	0.000818	CcSEcCtD
Clodronate—Abdominal pain—Doxorubicin—testicular cancer	0.000363	0.000814	CcSEcCtD
Clodronate—Diarrhoea—Methotrexate—testicular cancer	0.000363	0.000813	CcSEcCtD
Clodronate—Pruritus—Epirubicin—testicular cancer	0.000351	0.000787	CcSEcCtD
Clodronate—Diarrhoea—Epirubicin—testicular cancer	0.000339	0.000761	CcSEcCtD
Clodronate—Vomiting—Methotrexate—testicular cancer	0.000337	0.000756	CcSEcCtD
Clodronate—Rash—Methotrexate—testicular cancer	0.000334	0.000749	CcSEcCtD
Clodronate—Dermatitis—Methotrexate—testicular cancer	0.000334	0.000749	CcSEcCtD
Clodronate—Pruritus—Doxorubicin—testicular cancer	0.000325	0.000728	CcSEcCtD
Clodronate—Vomiting—Epirubicin—testicular cancer	0.000315	0.000707	CcSEcCtD
Clodronate—Nausea—Methotrexate—testicular cancer	0.000315	0.000706	CcSEcCtD
Clodronate—Diarrhoea—Doxorubicin—testicular cancer	0.000314	0.000704	CcSEcCtD
Clodronate—Rash—Epirubicin—testicular cancer	0.000313	0.000701	CcSEcCtD
Clodronate—Dermatitis—Epirubicin—testicular cancer	0.000312	0.000701	CcSEcCtD
Clodronate—Nausea—Epirubicin—testicular cancer	0.000295	0.000661	CcSEcCtD
Clodronate—Vomiting—Doxorubicin—testicular cancer	0.000292	0.000654	CcSEcCtD
Clodronate—Rash—Doxorubicin—testicular cancer	0.000289	0.000649	CcSEcCtD
Clodronate—Dermatitis—Doxorubicin—testicular cancer	0.000289	0.000648	CcSEcCtD
Clodronate—Nausea—Doxorubicin—testicular cancer	0.000273	0.000611	CcSEcCtD
